medication violation | Horse Racing Free Tips

PARX-Based Trainer Joe Taylor Latest to Be Provisionally Suspended by HIWU

According to a posting on the Horseracing Integrity and Welfare Unit (HIWU) website, Parx-based trainer Joe Taylor has been provisionally suspended after two horses he trained allegedly tested positive for banned substances.

On June 18, the Taylor-trained Cajun Cousin (Cajun Breeze) allegedly tested positive for Methylphenidate and Clenbuterol, both of which are banned substances. Two days later, Taylor sent out Classy American (Uncle Lino), who tested positive for the same two substances. Classy American finished second in a starter allowance while Cajun Cousin finished second in a $10,000 claimer.

Cajun Cousin would go on to win a $10,000 claiming race at Parx on July 12, before the results of the positive test had come back. She was claimed on July 12 by trainer Michael V. Pino for Smart Angle LLP. Under the Horseracing Integrity and Safety Authority (HISA)'s Anti-Doping and Medication Control (ADMC) program, a claim shall be voided if “the horse has a positive test for a prohibited substance.”

Methylphenidate is sold under the name of Ritalin, a common drug given to people battling attention deficit hyperactivity disorder. It has not been approved by the U.S. Food and Drug Administration (FDA) for use in horses. Clenbuterol is used for respiratory ailments but is also known for having steroid-like properties that can build muscle mass.

Taylor faces a suspension of up to two years.

Taylor led all trainers at Parx in 2019 when he had 103 winners. Training since 2010, he has 328 career wins from 2,011 starters.

The post PARX-Based Trainer Joe Taylor Latest to Be Provisionally Suspended by HIWU appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Pletcher Meets With Stewards Over Forte Hopeful Medication Violation

The three New York stewards met with Trainer Todd Pletcher and his representation Wednesday “regarding an alleged medication violation of a horse that raced in New York on September 5, 2022,” according to Brad Maione, Director of Communications for the New York State Gaming Commission. Maione was answering an email request from the TDN for information on the meeting.

“In this case, the matter likely would have been adjudicated months ago but for the repeated procedural delays sought by the trainer's counsel,” Maione wrote.

According to a report in Tuesday night's New York Times, the horse in question was Forte (Violence) after his win in the Hopeful S. He would go on to be the two-year-old champion and the Kentucky Derby favorite before being scratched the morning of the race with a bruised hoof.

Questions have been as to why Forte's positive test–both the initial sample and the residual or `B' sample–was not made public sooner.

“Today's meeting (which the Stewards refer to as a “Stewards' Hearing”) was simply an opportunity for the licensee to tell the Stewards the licensee's side of the story–a standard step in an investigative process. The three Stewards will consider the evidence and information involved in the matter, and then the State Steward will determine whether to issue a ruling for a violation. If and when a ruling is issued, it will be published online at https://rulings.gaming.ny.gov/,” he continued.

Maione said that in New York, as in most jurisdictions, the stewards identify horses to have both blood and urine samples drawn. Once samples are taken, they are shipped to the New York Equine Drug Testing & Research Laboratory in Ithaca for analysis, which usually takes approximately three weeks. If the laboratory detects and confirms the presence of a prohibited substance, the laboratory promptly informs the Commission, which promptly informs the State Steward at the racetrack where the horse's sample originated.

That “blind” positive is then matched, and an investigation into the matter is launched. The trainer is then given the option to have the residual sample tested at an approved laboratory at his own expense. If the B sample is also positive, the stewards may assess a fine or other penalty, and the trainer may challenge that penalty at an administrative hearing.

According to a press release from the Horse Racing Integrity & Welfare Unit Tuesday, once the AMDC goes into effect May 22, that is the point at which the information will be made publicly known in the future.

Said Maione, “In this case, two factors impacted the timeline:

1. The trainer exercised the opportunity to have a residual sample tested, which necessitated the trainer locating a separate RMTC-approved laboratory equipped to conduct the requisite test. In this case, several labs were contacted before finding a capable laboratory.

2. After the Commission and trainer received confirmation that the residual sample was also positive, the trainer's counsel has sought repeated postponement of the Stewards' Hearing, which impeded the Stewards from making a determination earlier.”

The post Pletcher Meets With Stewards Over Forte Hopeful Medication Violation appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Kentucky Commission Issues Medication Suspensions To Greg Foley, Phil Bauer

Trainers Greg Foley and Phil Bauer have each been issued suspensions by the Kentucky Horse Racing Commission, according to rulings posted to the Commission's website late last week.

Foley's trainee On Your Mark, winner of the eighth race at Ellis Park on Aug. 1, has been disqualified due to the presence of a metabolite of the sedative Acepromazine, a Class B medication violation. Foley has been fined $500 and issued a 15-day suspension, with 15 additional days stayed pending no additional violations (Class A or B) over the next 365 days.

Foley's suspension will run from Dec. 5 through Dec. 19, inclusive.

Bauer's trainees Angkor (third in Churchill's eighth race on June 18) and Played Hard (winner of Churchill's seventh race on June 20) were both found to have meloxicam in their post-race samples. Meloxicam is a non-steroidal anti-inflammatory classified as a Class B medication violation. Both Angkor and Played Hard have been disqualified, with Bauer fined $500 and suspended 30 days for each positive.

Since Bauer could not be notified of the first positive before the second occurred, his suspensions will run concurrently on Dec. 5, 2021 through Jan. 3, 2022.

The post Kentucky Commission Issues Medication Suspensions To Greg Foley, Phil Bauer appeared first on Horse Racing News | Paulick Report.

Source of original post

Third Class Four Medication Violation Of 2021 Filed Against Trainer Peter Miller

A class four medication violation complaint has been filed against trainer Peter Miller for the third time this year, reports the Thoroughbred Daily News.

His trainee Mr. Dougie Fresh tested positive for phenylbutazone after a breeze at San Luis Rey Downs training center on Sept. 19. Miller has not requested a split sample and is scheduled to appear before the California Horse Racing Board stewards.

The trainer's other class four (penalty category C) medication violations in 2021 include:

April 10: Miller was fined $500 for an Isoflupredone positive in Hembree, who won the seventh race at Santa Anita on Jan. 1.
Sept. 2: Miller was fined $1,500 for a phenylbutazone overage after a June 19 workout at San Luis Rey Downs, as well as .5 points in accordance with the CHRB's multiple medication violations rule.

Read more at the Thoroughbred Daily News.

The post Third Class Four Medication Violation Of 2021 Filed Against Trainer Peter Miller appeared first on Horse Racing News | Paulick Report.

Source of original post